In addition, a Spanish study of more than 12,000 patients observed that hypertension among patients treated with angiotensin-converting enzyme inhibitors or renin-angiotensin-aldosterone blockers or angiotensin II receptor blockers was significantly associated with lower all-cause mortality (30). This evidence concerns the gene REN and hypertensive disorder.